Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bruker Corp (BRKR)
NASDAQ:BRKR
Holding BRKR?
Track your performance easily
Earnings Data
Report Date
Feb 18, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
$0.74Last Year’s EPS
$0.7Same Quarter Last Year
Moderate Buy
Based on 13 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 05, 2024
|% Change Since: -3.88%
|Next Earnings Date:Feb 18, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture. While Bruker showed strong revenue growth driven by strategic acquisitions and segments like semiconductor metrology, the company faced significant challenges in the biopharma and China markets, leading to reduced fiscal year guidance and impacting margins and earnings. These factors resulted in a more cautious outlook for the near term.Company Guidance
In the third quarter of 2024, Bruker Corporation achieved a constant exchange rate (CER) revenue growth of 15.7% year-over-year, driven by strategic acquisitions and organic growth of 3.1%. The Bruker Scientific Instruments (BSI) segment reported an organic revenue growth of 3.8%. The company's reported revenues reached $864.4 million, marking a 16.4% increase from the previous year, with a currency tailwind contributing 0.7%. However, the non-GAAP operating margin decreased by 510 basis points to 14.9%, primarily due to recent strategic acquisitions, which initially diluted margins. The company's non-GAAP diluted EPS was $0.60, a 19% decline from $0.74 in the third quarter of 2023. Despite these challenges, Bruker anticipates double-digit CER revenue growth in the fourth quarter of 2024, with expectations for low single-digit organic revenue growth compared to a strong fourth quarter in 2023. The guidance for fiscal year 2024 has been adjusted, now projecting a CER revenue growth of approximately 13% and organic growth of 3% to 4%, with ongoing efforts to improve margins and integrate recent acquisitions to drive future growth.Strong Revenue Growth
Bruker's Q3 '24 reported revenues increased 16.4% year-over-year to $864.4 million, with a CER revenue growth of 15.7% and organic revenue growth of 3.1%.
Strategic Acquisitions Impact
The acquisitions added approximately $500 million in revenues, leading to a CER revenue growth of 15.7% year-over-year.
Semiconductor Metrology and Diagnostics Growth
Strong demand in semiconductor metrology and diagnostics, particularly MALDI Biotyper and ELITech Molecular Diagnostics, showed robust performance.
---
BRKR Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
BRKR Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 05, 2024 | $59.30 | $61.29 | +3.36% |
| Aug 06, 2024 | $63.44 | $62.06 | -2.18% |
| May 02, 2024 | $78.84 | $69.92 | -11.31% |
| Feb 13, 2024 | $70.39 | $76.56 | +8.77% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Bruker Corp (BRKR) report earnings?
Bruker Corp (BRKR) is schdueled to report earning on Feb 18, 2025, TBA Not Confirmed.
What is Bruker Corp (BRKR) earnings time?
Bruker Corp (BRKR) earnings time is at Feb 18, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BRKR EPS forecast?
BRKR EPS forecast for the fiscal quarter 2024 (Q4) is $0.74.
---